Skip to content

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Clinical Protocol REN-007E - Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Subjects Enrolled in Study REN-007

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06092970
Enrollment
353
Registered
2023-10-23
Start date
2023-10-16
Completion date
2026-02-06
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Operative Complications in Cardiac Surgery

Brief summary

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes

Interventions

DRUGRBT-1

Intravenous administration

DRUGPlacebo

Intravenous administration

Sponsors

Renibus Therapeutics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study.

Exclusion criteria

* Subjects who did not complete the REN-007 study are not eligible to participate in the Extension Study. * Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation12 Months Post-Cardiac SurgeryTo evaluate patient reported outcomes (PRO) using the EQ-5D questionnaire

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026